Quinapril hydrochloride is an angiotensin-converting enzyme (ACE) inhibitor prescribed for the management of hypertension and heart failure. By inhibiting the conversion of angiotensin I to angiotensin… Read more
Quinapril hydrochloride is an angiotensin-converting enzyme (ACE) inhibitor prescribed for the management of hypertension and heart failure. By inhibiting the conversion of angiotensin I to angiotensin II, it helps lower blood pressure and improve cardiac function. Its primary active metabolite, quinaprilat, is formed in the liver to exert therapeutic effects. This category includes high-quality reference standards for the parent drug substance alongside its pharmacopeial and non-pharmacopeial impurities, degradation products, and stable isotope-labelled compounds. Pharmaceutical laboratories utilize these materials for rigorous impurity profiling, method validation, and ongoing quality control of the active pharmaceutical ingredient. These standards ensure the accuracy and reliability of analytical procedures during the development and stability testing of drug formulations.